$8.67 -0.30 (-3.34%)
11/25/2009 4:00 PM

BioCryst Pharmaceuticals, Inc. (BCRX)

CAPS Rating: 1 out of 5

A biotechnology company, which designs, optimizes and develops novel drugs that block key enzymes involved in cancer, cardiovascular diseases, autoimmune diseases, and viral infections.

Featured Broker Partners